Integra Lifesciences Holdings (IART) Amortizatization of Intangibles (2011 - 2026)
Integra Lifesciences Holdings' (IART) quarterly Amortizatization of Intangibles came in at $1.0 million in Q2 2026, down 46.03% year-over-year from $1.9 million in Q2 2025, and up 2.51% quarter-over-quarter from $995000.0 in Q1 2026.
Analysis
Integra Lifesciences Holdings (IART) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
Integra Lifesciences Holdings has disclosed Amortizatization of Intangibles across 14 years of filings, most recently posting $1.0 million for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 46.03% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $4.3 million (down 27.7% YoY), while the FY2025 annual figure was $5.6 million, changed 0.21% from the prior year.
- Amortizatization of Intangibles came in at $1.0 million for Q2 2026 at Integra Lifesciences Holdings, up from $995000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.9 million in Q1 2023 to a low of $995000.0 in Q1 2026.
- Average Amortizatization of Intangibles over 5 years is $1.5 million, with a median of $1.4 million recorded in 2023.
- Year-over-year, Amortizatization of Intangibles rose 29.45% in 2025 and sank 46.03% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at $1.7 million in 2022, then declined by 15.85% to $1.4 million in 2023, then declined by 2.3% to $1.4 million in 2024, then decreased by 27.5% to $1.0 million in 2025, then rose by 0.49% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.0 million in Q2 2026, $995000.0 in Q1 2026, and $1.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn | 1.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 995,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 1.74 Mn |